Cancer Control in Low- and Middle-income Countries: Time for Action

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2019 May 25

PMID 31124403

Citations 5

Authors

Berkin Hack

Katy Piddock

Susannah Stanway

Kirsty Balachandran

Ruth Board

Neha Chopra

David Okonji

Bhawna Sirohi

Richard Sullivan

Katie Wakeham

Affiliations

Soon will be listed here.

Citing Articles

Outcomes and Toxicities After Treatment for Men Diagnosed With Localized Prostate Cancer in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.

Kitson-Mills D, Donkor A, Amoako Y, Kyei K, Bonsu E, Vanderpuye V Adv Radiat Oncol. 2025; 10(1):101670.

PMID: 39758977 PMC: 11699425. DOI: 10.1016/j.adro.2024.101670.

Unveiling the potential of Muscadine grape Skin extract as an innovative therapeutic intervention in cancer treatment.

Otun S, Achilonu I, Odero-Marah V J Funct Foods. 2024; 116.

PMID: 38817632 PMC: 11139022. DOI: 10.1016/j.jff.2024.106146.

A Review of the Current State of Global Surgical Oncology and the Role of Surgeons Who Treat Cancer: Our Profession's Imperative to Act Upon a Worldwide Crisis in Evolution.

Saunders A, Mutebi M, Subramanyeshwar Rao T Ann Surg Oncol. 2023; 30(6):3197-3205.

PMID: 36973564 PMC: 10175401. DOI: 10.1245/s10434-023-13352-3.

Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: a scoping review.

Udayakumar S, Solomon E, Isaranuwatchai W, Rodin D, Ko Y, Chan K Support Care Cancer. 2022; 30(8):6463-6471.

PMID: 35322274 DOI: 10.1007/s00520-022-06952-4.

Data sharing and opening up research.

Abbasi K J R Soc Med. 2019; 112(6):211.

PMID: 31163119 PMC: 6552381. DOI: 10.1177/0141076819855176.

References

Farmer P, Frenk J, Knaul F, Shulman L, Alleyne G, Armstrong L . Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010; 376(9747):1186-93. DOI: 10.1016/S0140-6736(10)61152-X. View

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S . Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9):e609-16. DOI: 10.1016/S2214-109X(16)30143-7. View

Pfaendler K, Mwanahamuntu M, Sahasrabuddhe V, Mudenda V, Stringer J, Parham G . Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008; 110(3):402-7. PMC: 2745977. DOI: 10.1016/j.ygyno.2008.04.031. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Bray F, Jemal A, Grey N, Ferlay J, Forman D . Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012; 13(8):790-801. DOI: 10.1016/S1470-2045(12)70211-5. View

Parham G, Mwanahamuntu M, Kapambwe S, Muwonge R, Bateman A, Blevins M . Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169. PMC: 4401717. DOI: 10.1371/journal.pone.0122169. View

Atun R, Jaffray D, Barton M, Bray F, Baumann M, Vikram B . Expanding global access to radiotherapy. Lancet Oncol. 2015; 16(10):1153-86. DOI: 10.1016/S1470-2045(15)00222-3. View

Sayed S, Lukande R, Fleming K . Providing Pathology Support in Low-Income Countries. J Glob Oncol. 2017; 1(1):3-6. PMC: 5551652. DOI: 10.1200/JGO.2015.000943. View

Hiom S . Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer. 2015; 112 Suppl 1:S1-5. PMC: 4385969. DOI: 10.1038/bjc.2015.23. View

10.

Fojo T, Mailankody S, Lo A . Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture. JAMA Otolaryngol Head Neck Surg. 2014; 140(12):1225-36. DOI: 10.1001/jamaoto.2014.1570. View

11.

Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R . Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. Gynecol Oncol Rep. 2018; 25:65-69. PMC: 6008286. DOI: 10.1016/j.gore.2018.05.005. View

12.

Schroeder L, Amukele T . Medical laboratories in sub-Saharan Africa that meet international quality standards. Am J Clin Pathol. 2014; 141(6):791-5. DOI: 10.1309/AJCPQ5KTKAGSSCFN. View

13.

Vineis P, Wild C . Global cancer patterns: causes and prevention. Lancet. 2013; 383(9916):549-57. DOI: 10.1016/S0140-6736(13)62224-2. View

14.

Sullivan R, Alatise O, Anderson B, Audisio R, Autier P, Aggarwal A . Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015; 16(11):1193-224. DOI: 10.1016/S1470-2045(15)00223-5. View

15.

Sirohi B, Chalkidou K, Pramesh C, Anderson B, Loeher P, El Dewachi O . Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. Lancet Oncol. 2018; 19(8):e395-e406. DOI: 10.1016/S1470-2045(18)30342-5. View

16.

Franzen S, Chandler C, Lang T . Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature. BMJ Open. 2017; 7(1):e012332. PMC: 5278257. DOI: 10.1136/bmjopen-2016-012332. View

17.

Mahal A, Karan A, Fan V, Engelgau M . The economic burden of cancers on Indian households. PLoS One. 2013; 8(8):e71853. PMC: 3741186. DOI: 10.1371/journal.pone.0071853. View

18.

. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1459-1544. PMC: 5388903. DOI: 10.1016/S0140-6736(16)31012-1. View